News Hub

Real-time financial, economic, and global news with market-focused context and analysis.

Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.

  • Ford's ability to shift production between ICE and EV lines supports a tactical long as truck demand stabilizes.
  • Broadcom's roughly 28–30% pullback from its 52-week high creates a buy opportunity based on strong cash flow and defined risk.
  • Telkom Indonesia's infrastructure spinoff clarifies earnings and could trigger a valuation re-rating into Q3.
  • Traders are favoring defined-entry, stop-based trades in discounted cyclicals and tech amid recent pullbacks.
  • Recommended setups focus on mid-term horizons and tight stops to limit downside during EV and macro normalization.

Latest Articles

Rating Upgrade: SMCI Looks Like a Rare AI-Infrastructure Value Play

Rating Upgrade: SMCI Looks Like a Rare AI-Infrastructure Value Play

Super Micro Computer (SMCI) is benefitting from explosive AI data-center demand: fiscal 2026 revenue surged to $39.1B and management is guiding fiscal 2027 sales of $65-72B with AI solutions expected to exceed 80% of revenue. At a market cap near $27.5B and a forward P/E in the low-teens, the stock now offers a compelling risk-reward. This trade id…

SI-BONE Receives FDA 510(k) Clearance for iFuse Granite Onyx™, Extending Its Compromised Bone Franchise Beyond the Pelvis

SI-BONE Receives FDA 510(k) Clearance for iFuse Granite Onyx™, Extending Its Compromised Bone Franchise Beyond the Pelvis

SI-BONE, Inc. (Nasdaq: SIBN) received FDA 510(k) clearance for its iFuse Granite Onyx System, its first product targeting compromised bone outside the pelvis. This spinal fusion technology is designed specifically to reduce screw loosening at critical vertebrae in patients with poor bone quality, addressing an unmet clinical need that affects up to…

Applied Digital Sets Fiscal First Quarter 2027 Conference Call for Wednesday, October 7, 2026, at 5:00 p.m. Eastern Time

Applied Digital Sets Fiscal First Quarter 2027 Conference Call for Wednesday, October 7, 2026, at 5:00 p.m. Eastern Time

Applied Digital Corporation, a U.S.-based owner and operator of data centers tailored for high-performance computing and AI workloads, will host a conference call on October 7, 2026, to discuss fiscal Q1 2027 financial results. The company highlights its continued focus on HPC infrastructure, rapid deployment capabilities, and economic development …

AMD to Acquire World Labs to Advance the Future of AI Compute

AMD to Acquire World Labs to Advance the Future of AI Compute

AMD announced an $8.2 billion all-stock deal to acquire World Labs, an AI model and research lab led by Dr. Fei-Fei Li. The acquisition aims to enhance AMD's AI compute capabilities by integrating advanced AI model research into its hardware and software development, positioning AMD to better address emerging AI workloads and applications. Dr. Li w…

Adeia Appoints Dipti Vachani as Chief Executive Officer

Adeia Appoints Dipti Vachani as Chief Executive Officer

Adeia Inc. announced the appointment of Dipti Vachani as chief executive officer effective October 12, 2026. Vachani brings nearly 30 years of semiconductor industry experience with leadership roles at Arm, Intel, Skyworks, and Texas Instruments. She succeeds Paul Davis, who is stepping down for health reasons but will assist in transition. The new…

Attovia Therapeutics to Present New Data on ATTO-1310 and ATTO-2306 at EADV 2026 and Fall Clinical Dermatology Conference 2026

Attovia Therapeutics to Present New Data on ATTO-1310 and ATTO-2306 at EADV 2026 and Fall Clinical Dermatology Conference 2026

Attovia Therapeutics announced presentations of new clinical and preclinical data for its ATTO-1310 and ATTO-2306 immunotherapies targeting IL-31 and IL-13 at the 2026 European Academy of Dermatology and Venereology Congress and Fall Clinical Dermatology Conference. Data includes Phase 1a safety results, translational insights on IL-31 in pruritic …

Teva Continues Biosimilar Momentum with U.S. FDA Approval of DEGEVMA™ (denosumab-adet), a Biosimilar to Xgeva® (denosumab)

Teva Continues Biosimilar Momentum with U.S. FDA Approval of DEGEVMA™ (denosumab-adet), a Biosimilar to Xgeva® (denosumab)

Teva Pharmaceutical Industries received FDA approval for DEGEVMA™, a biosimilar to Amgen's Xgeva®, indicated for prevention of bone complications in adults with advanced cancer that has metastasized to the bone, treatment of giant cell tumor of bone, and hypercalcemia of malignancy. This approval complements the earlier FDA approval of PONLIMSI™, e…

Star Fashion Culture Holdings Limited  Announces Closing of Approximately US$9,600,000 Public Offering of Class A Ordinary Shares

Star Fashion Culture Holdings Limited Announces Closing of Approximately US$9,600,000 Public Offering of Class A Ordinary Shares

Star Fashion Culture Holdings Limited (NASDAQ: STFS) announced the closing of a best-efforts follow-on public offering of 12 million Class A ordinary shares at $0.80 per share, raising gross proceeds of approximately $9.6 million. The net proceeds will be used to develop the company's online marketing services and support general administration and…

OPPJ: Faint Rally, Big Vulnerabilities - A Mid-Term Short Setup

OPPJ: Faint Rally, Big Vulnerabilities - A Mid-Term Short Setup

WisdomTree Japan Opportunities Fund (OPPJ) has delivered strong recent returns and sits near its 52-week high, but technical momentum is waning and liquidity is thin. Combine a modest valuation, heavy short-volume spikes, and dynamic currency-hedge dynamics and you get a tactical short opportunity. Entry $59.32, target $52.00, stop $62.00. Hold for…

Buyback Boost: Trade Nvidia on the $150B Repurchase Reaction

Buyback Boost: Trade Nvidia on the $150B Repurchase Reaction

Nvidia just expanded its repurchase program by $150 billion, lifting total authorization to $235 billion through fiscal 2028. The combination of huge free cash flow, modest leverage, and bullish technicals creates a tradeable mid-term long setup. Enter near current levels, size carefully, and use a defined stop below the recent consolidation low.

Scripps taps Sean McGarvy to lead news strategy

Scripps taps Sean McGarvy to lead news strategy

The E.W. Scripps Company has appointed Sean McGarvy as head of news starting October 5, 2026. McGarvy will oversee news and content strategy across Scripps News Group's local newsrooms, digital platforms, and national streaming network, aiming to expand the reach and impact of Scripps journalism across broadcast, streaming, and digital channels. Hi…

Coinbase: Trade the Momentum, Not the Clarity

Coinbase: Trade the Momentum, Not the Clarity

Coinbase is trading below the midpoint of its 52-week range but above key moving averages after recent approvals and a crypto price rebound. The company generates meaningful free cash flow, trades at a premium multiple, and carries elevated short interest—creating a setup that favors a disciplined momentum trade. This is a swing trade with explicit…